This $0.78 Pot Stock Soared 30% in 1 Month; More to Come?
Time to Check Out This Low-Priced Pot Stock
“If Auxly Cannabis Group Inc manages to deliver on its pot derivatives plan in the fourth quarter of 2019 and beyond, the CBWTF stock price could go much, much higher.”
That’s what I told readers of Profit Confidential about Auxly Cannabis Group Inc (OTCMKTS:CBWTF, CVE:XLY) in early July. In that piece, I explained why this low-priced pot stock could see material upside.
I hope you took advantage of that opportunity. When I wrote that story, Auxly Cannabis stock was priced at $0.59 per share. Today, CBWTF stock trades at $0.78 apiece, marking a gain of more than 30% in just one month.
The best part is, the opportunity might not be over just yet. For investors looking for pot stocks that have serious upside potential, Auxly Cannabis stock remains one of the top names to consider.
Compared to the big pot companies trading on major U.S. stock exchanges, Auxly Cannabis Group is a relatively small player in the business. But the company does help investors get exposure to the different aspects of the booming cannabis industry: Auxly focuses on the medical, wellness, and recreational weed markets.
The company boasts a diversified supply chain. In particular, it has wholly owned pot growing subsidiaries, offtake and streaming agreements with other growers, and a joint venture project for large-scale greenhouse cannabis cultivation.
Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Stock Chart
Chart courtesy of StockCharts.com
Why Auxly Cannabis Stock Was Soaring
To be honest, I knew CBWTF stock had upside potential, but I didn’t know that its price could rise so quickly. In fact, the recent surge in Auxly Cannabis stock was primarily due to an unexpected announcement.
On July 25, Auxly announced that Imperial Brands PLC (OTCMKTS:IMBBY, LON:IMB) would invest around CA$123.0 million in the company. (Source: “Auxly Welcomes $123 Million Investment and R&D Partnership with Imperial Brands,” GlobeNewswire, July 25, 2019.)
Under the agreement, Imperial Brands will invest in Auxly Cannabis Group’s convertible debenture and grant Auxly global licenses to its vaping technology and access to its vapor innovation business, Nerudia.
Imperial Brands is one of the largest tobacco companies in the world. In its last fiscal year, the company generated more than £30 billion in revenue.
“This investment from Imperial Brands will enhance Auxly’s ability to continue to deliver on our business plans and accelerate our growth initiatives to expand our portfolio of branded derivative products,” said Auxly Cannabis Group Inc President Hugo Alves. (Source: Ibid.)
“The timing is ideal as we prepare to bring our portfolio of innovative cannabis products to the Canadian market following the legalization of edibles, extracts and topicals later this year,” he continued.
Mind you, this is not the first time for a tobacco company to make a foray into the booming marijuana industry. In December 2018, Altria Group Inc (NYSE:MO), the maker of “Marlboro” cigarettes, announced a CA$2.4-billion investment in Canadian pot producer Cronos Group Inc (NASDAQ:CRON). (Source: “Altria to Make Growth Investment in Cronos Group,” Altria Group Inc, December 7, 2018.)
A Major Opportunity on the Horizon
Receiving an investment from a tobacco giant is certainly good news, especially when you take into account what Auxly Cannabis Group Inc has been working on.
You see, Auxly is preparing for what’s called the “second wave” of legalization. The Canadian government legalized recreational marijuana on October 17, 2018. That is referred to as the “first wave.” This October, the country is expected to legalize derivative cannabis products such as concentrates, edibles, and topicals for recreational use—the second wave.
The neat thing about derivatives is that they tend to have much higher margins than dried cannabis flower. Therefore, once these products get legalized, Auxly could improve not just its revenue, but also its profitability.
And with access to Imperial Brands’ leading vaping technology and its research and development capabilities, Auxly Cannabis now has a better chance of capitalizing on Canada’s second wave of marijuana legalization.
Analyst Take
Ultimately, keep in mind that the stock market is facing a lot of uncertainly at the moment, and some analysts are forecasting a major downturn on the horizon.
In the past, what we’ve seen is that, when there is a pullback in the overall market, investors tend to first sell the stocks that went up the most. And since pot stocks have been some of the biggest gainers for the past two years or so, the industry could take a big hit if there’s a market correction.
Still, the growth theme at Auxly Cannabis Group Inc remains intact. And the investment from a major tobacco company should boost its competitiveness in the business. In the long run, CBWTF stock investors could get rewarded big time.
